Los estudios farmacéuticos: alcances y limitaciones de un campo de indagación emergente
Resumen
Los estudios farmacéuticos han cobrado fuerza recientemente como un campo de indagación teórica y empírica particular, centrándose en la caracterización del papel preponderante que la industria farmacéutica y la circulación de sus productos desempeñan en las sociedades contemporáneas. En este artículo se examinan los orígenes del campo, se revisan las principales investigaciones que han jalonado su surgimiento, así como se discuten las principales elaboraciones teóricas que sustentan su especificidad. Se revisan así los tres ejes fundamentales que han contribuido a su conformación: 1) el establecimiento de una tradición de estudios sociales sobre la industria farmacéutica y los medicamentos 2) la delimitación como objeto de análisis y estudio de las particulares prácticas científico-tecnológicas que sustentan el desarrollo de medicamentos y su difusión en los mercados 3) la generación de nociones teóricas para dar cuenta del poder transformador de la industria farmacéutica y sus productos. Por último, se discute los alcances y limitaciones de este nuevo campo de indagación.Referencias bibliográficas
Abraham, J. (2010a). The sociological concomitants of the pharmaceutical industry and medications. En C. Brid, P. Conrad, A.M. Fremnto, y S. Timmermans (Eds.), Handbook of medical sociology (pp. 290-308). Nashvill: Vanderbilt University Press.
Abraham, J. (2010b). Pharmaceuticalization of Society in Context: Theoretical, Empirical and Health Dimensions. Sociology, 44(4), 603-622.
Achilladelis, B. y Antonakis, N. (2001). The dynamics of technological innovation: the case of the pharmaceutical industry. Research Policy, 30, 535-588.
Angell, M. (2004). The Truth About the Drug Companies: How they Deceive us and What to do About it. New York: Randon House.
Bell, S. E. y Figert, A. E. (2012). Medicalization and pharmaceuticalization at the intersection: Looking backward, sideways and forward. Social Sciences and Medicine, 75(5), 775-783.
Biehl, J. (2006). Pharmaceutical governance. En A. Petryna, A. Lakoff y A. Kleinman (Eds.), Global Pharmaceuticals: Ethics, markets, practices (pp. 206-239). Berkeley: University of California.
Bielli, A. (2008). Psicofármacos bajo la mirada de los estudios de Ciencia, Tecnología y Sociedad. En Centro Cultural de España (Ed.), Ciencia, Tecnología y Sociedad (pp.165-180). Montevideo: Autor.
Bielli, A. (2012). La introducción de los antidepresivos en Uruguay (1950-2000): transformaciones de los saberes psicológicos. Montevideo: CSIC.
Braithwaite, J. (1986 [1984]). Corporate Crime in the pharmaceutical industry. Boston: Routledge & Kegan Paul.
Busfield, J. (2006). Pills, Power, People: Sociological Understandings of the Pharmaceutical Industry. Sociology, 40(2), 297-314.
Busfield, J. (2010). ‘A pill for every ill’: Explaining the expansion in medicine use. Social Science & Medicine, 70, 934-941.
Conrad, P. (2005). The Shifting Engines of Medicalization. Journal of Health and Social Behavior, 46 (March), 3-14.
Coopersotck, R y Lennard, H. (1979). Some social meanings of tranquilizer use. Sociology of Health and Illness, 1(3), 331-347.
Dehue, T. (2010). Comparing Artificial Groups: On the History and Assumptions of the Randomised Controlled Trials. En C. Will y T. Moreira (Eds.) Medical Proofs, Social Experiments: Clinical Trials in Shifting Contexts (pp. 103-120). Farnham: Ashgate Publishing.
Dumit, J. (2002). Drugs for Life. Molecular Interventions, 2(3) 124-127.
Dumit, J. (2003). Is It Me or My Brain? Depression and Neuroscientific Facts. Journal of Medical Humanities, 24(1/2): 35-47.
Dumit, J. (2012). Drugs for Life. How Pharmaceutical Companies Define our Health. Durhma: Duke University Press.
Dumit, J. y Greenslit, N. (2006). Informated Health and Ethical Identity Management. Culture, Medicine and Psychiatry, 30, 127-134.
Fox, N. J. y Ward, K.J. (2008). Pharma in the bedroom and the kitchen. The pharmaceuticalization of daily life. Sociology of Health & Illness, 30(6), 856-868.
Fox, R. (1997 [1959]). Experiment Perilous: Physicians and Patients Facing the Unknown. New Brunswick: Transaction Books.
Gabe, J. y Lipshitz-Phillips, S. (1984). Tranquillisers as social control? Sociological Review, 32(3), 524-546.
Gabe, J., Williams, S., Martin, P. y Coveney, C. (2015). Pharmaceuticals and society: Power, promises and prospects. Social Science & Medicine, 131, 193-198.
Healy, D. (2000 [1997]). The Antidepressant Era.Cambridge, MA: Harvard University Press.
Healy, D. (2004). Shaping the Intimate: Influences on the Experience of Everyday Nerves. Social Studies of Science,34(2), 219-245.
Healy, D. (2012). Pharmageddon. Berkeley: University of California Press.
Jenkins, J. H. (2011a). Introduction. En J. H. Jenkins (Ed.), Pharmaceutical Self: The Global Shaping of Experience in an Age of Psychopharmacology (pp. 3-16). Santa Fe: School for Advanced Research Press.
Jenkins, J. H. (2011b). Psychopharmaceutical Self and Imaginary in the Social Field of Psychiatric Treatment. En J. H. Jenkins (Ed.), Pharmaceutical Self: The Global Shaping of Experience in an Age of Psychopharmacology (pp. 17-40). Santa Fe: School for Advanced Research Press.
Lakoff, A. (2000). Adaptive Will: The Evolution of Attention Deficit Disorder. Journal of the History of the Behavioural Sciences, 36(2): 149-169.
Lakoff, A. (2004). The Anxieties of Globalization: Antidepressant Sales and Economics Crisis in Argentina. Social Studies of Science, 34(2): 247-269.
Lakoff, A. (2005). Pharmaceutical Reason. Knowledge and Value in Global Psychiatry. Cambridge: Cambridge University Press.
Lakoff, A. (2006). High Contact. Gifts and Surveillance in Argentina. En A. Petryna, A. Lakoff y A. Kleinman (Eds.), Global Pharmaceuticals: Ethics, markets, practices (pp. 111-135). Berkeley: University of California.
Liebenau, J. (1987). Medical Science and Medical Industry. The Formation of the American Pharmaceutical Industry. Hong Kong: Macmillan Press.
Mamo, L. y Epstein, S. (2014). The pharmaceuticalization of sexual risk: vaccine development and the new politics of cancer prevention. Social Science & Medicine, 101, 155-165.
Marks, H. M. (1997). The Progress of Experiment Science and Therapeutic Reform in the United States. 1900-1990. New York: Cambridge University Press.
Martin, E. (2006). The Pharmaceutical Person. BioSocieties, 1, 273-287.
Mirowski, P. y Van Horn, R. (2005). The Contract Research Organization and the Commercialization of Scientific Research. Social Studies of Sciences, 35(4), 503-548.
Moncrieff, J. (2006). Psychiatric drug promotion and the politics of neoliberlism. British Journal of Psychiatry, 188, 301-302.
Moynihan, R., Heath, I. y Henry, D. (2002). Selling sickness: the pharmaceutical industry and disease mongering. British Medical Journal, 234, 886-890.
Nichter, M. (2003 [1989]). Pharmaceuticals, the commodification of health, and the health care-medicine use transition. En M. Nichter y M. Nichter (Eds.), Anthropology and international health: Asian case studies (pp. 268-333). London: Routledge Taylor & Francis Group.
Petryna, A. (2006). Globalizing Human Subjects Research. En A. Petryna, A. Lakoff y A. Kleinman (Eds.), Global Pharmaceuticals: Ethics, markets, practices (pp. 33-60). Berkeley: University of California.
Reynolds Whyte, S., van der Geest y Hardon, A. (2002). Social Lives of Medicines. Cambridge: Cambridge University Press.
Singh, I. (2002). Bad Boys, Good Mothers, and the “Miracle” of Ritalin. Science in Context, 15(4): 577-603.
Sismondo, S. (2004). Pharmaceutical Maneuvers. Social Studies of Science, 34(2),149-159.
Sismondo, S. (2008). How pharmaceutical industry fundings affects trial outcomes: Causal structures and responses. Social Science & Medicine, 66, 155-165.
Sismondo, S. y Greene, J. A. (2015). Introduction. En S. Sismondo y J. A. Greene (Eds.) The Pharmaceutical Studies Reader (pp. 1-16). Chichester: Wiley-Blackwell.
van der Geest, S., Reynolds Whyte, S. y Hardon, A. (1996). The Anthropology of Pharmaceuticals: A Biographical Approach. Annual Review of Anthropology, 25, 153-178.
Vos, R. (1991). Drugs Looking for Diseases: Innovative Drug Research and the Development of the Beta Blockers and the Calcium Antagonists. Dordrecht: Springer Neatherlands.
Williams, S., Gabe, J. y Davis, P. (2008). The sociology of pharmaceuticals: progress and prospects. Sociology of Health & Illness, 30(6), 813–824.
Williams, S., Martin, P, y Gabe, J. (2011). The pharmaceuticalisation of society? A framework for analysis. Sociology of Health & Illness,33(5), 710–725.
Tone, A. (2009). The Age of Anxiety: A History of America’s Turbulent Affair with Tranquilizers. New York: Basic Books.
Descargas
